Viewing StudyNCT03153111

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 10:05 AM
Last Modification Date: 2024-10-26 @ 12:24 PM
Study NCT ID: NCT03153111
Status: COMPLETED
Last Update Posted: 2023-05-03
First Post: 2017-03-30
Brief Title: A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
Sponsor: Actelion
Organization: Actelion
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Heart Failure With Preserved Ejection Fraction
Keywords: